0001209191-17-035372.txt : 20170525 0001209191-17-035372.hdr.sgml : 20170525 20170525162716 ACCESSION NUMBER: 0001209191-17-035372 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170523 FILED AS OF DATE: 20170525 DATE AS OF CHANGE: 20170525 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HARVARD BIOSCIENCE INC CENTRAL INDEX KEY: 0001123494 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 043306140 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 84 OCTOBER HILL RD CITY: HOLLISTON STATE: MA ZIP: 01746 BUSINESS PHONE: 5088938999 MAIL ADDRESS: STREET 1: 84 OCTOBER HILL ROAD CITY: HOLLISTON STATE: MA ZIP: 01746 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEWIS EARL R CENTRAL INDEX KEY: 0001230427 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33957 FILM NUMBER: 17870330 MAIL ADDRESS: STREET 1: C/O NXSTAGE MEDICAL INC. (NXTM) STREET 2: 439 SOUTH UNION STREET, 5TH FLOOR CITY: LAWRENCE STATE: MA ZIP: 01843 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-05-23 0 0001123494 HARVARD BIOSCIENCE INC HBIO 0001230427 LEWIS EARL R 87 PINCKNEY STREET BOSTON MA 02114 1 0 0 0 Common Stock 2017-05-23 4 P 0 5000 2.39 A 428012 D Common Stock 2017-05-24 4 P 0 5000 2.37 A 433012 D This transaction was executed in multiple trades at prices ranging from $2.37 to $2.40. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Includes (a) a deferred stock award of 23,250 restricted stock units which vest quarterly in equal installments on June 30, 2017, September 30, 2017 and December 31, 2017; and (b) 404,762 shares of common stock held by the Reporting Person. Includes (a) a deferred stock award of 23,250 restricted stock units which vest quarterly in equal installments on June 30, 2017, September 30, 2017 and December 31, 2017; and (b) 409,762 shares of common stock held by the Reporting Person. This form has been signed under power of attorney. /s/ Chad Porter, by power of attorney 2017-05-25